Table 1.
Duplication time (h) | μ (h-1) | Maximal cellular densities (×103) | |||||||
---|---|---|---|---|---|---|---|---|---|
Control | NH4Cl (mM) | Control | NH4Cl (mM) | Control | NH4Cl (mM) | ||||
+5 | +10 | +5 | +10 | +5 | +10 | ||||
Metastatic cells | |||||||||
MDA-MB-231 | 32 ± 1 | 26 ± 3 * | 25 ± 1* | 0.47 ± 0.05 | 0.61 ± 0.06* | 0.9 ± 0.07* | 82 ± 16 | 145 ± 13* | 142 + 17* |
HeLa | 31 ± 3 | 25.5 ± 2* | 24 ± 2* | 0.63 ± 0.04 | 0.77 ± 0.03* | 0.8 ± 0.05* | 87 ± 9 | 153 ± 13* | 163 ± 9* |
PC3 | 36 ± 2 | 28 + 2* | 26 ± 1* | 0.57 ± 0.06 | 1.01 ± 0.04* | 1.05 ± 0.03* | 68 ± 3.5 | 136 ± 2* | 141 ± 1.4* |
HCT116 | 69 ± 3 | 45 ± 1* | 39 ± 2* | 0.36 ± 0.05 | 0.49 ± 0.03* | 0.51 ± 0.02* | 45 ± 7 | 76 ± 11* | 80 ± 13* |
Colo 205 | 80 ± 5 | 48 ± 2* | 44 ± 4* | 0.53 ± 0.02 | 0.62 ± 0.05* | 0.63 ± 0.04* | 45 ± 7 | 68 ± 6* | 66 ± 6* |
Low metastatic cells | |||||||||
MCF-7 | 34 ± 1 | 37 ± 2 | 45 ± 6 | 0.34 ± 0.05 | 0.38 ± 0.02 | 0.69 ± 0.03* | 44 ± 7 | 72 ± 6* | 76 ± 5* |
SiHa | 48 ± 3 | 51 ± 4 | 55 ± 5 | 0.60 ± 0.04 | 0.58 ± 0.05 | 0.55 ± 0.07 | 90 ± 6 | 86 ± 7 | 82 ± 5 |
DU145 | 26 ± 2 | 32 ± 2* | 35 ± 3* | 1.0 ± 0.06 | 0.47 ± 0.07* | 0.55 ± 0.04* | 106 ± 8 | 92 ± 6 | 85 ± 4* |
A549 | 25 ± 3 | 20 ± 2 | 17 ± 3* | 0.78 ± 0.05 | 0.82 ± 0.04 | 0.85 ± 0.06* | 41 ± 5 | 49 ± 4 | 56 ± 2* |
Non-cancer cells | |||||||||
3T3 | 26 ± 0.5 | 46 ± 2* | 60 ± 1* | 0.7 ± 0.02 | 0.43 ± 0.1* | 0.32 ± 0.003* | 131 ± 5 | 45 ± 3* | 36 ± 2* |
HFF-1 | 32 ± 7 | 38 ± 12 | 55 ± 2* | 0.75 ± 0.1 | 0.65 ± 0.08 | 0.4 ± 0.1* | 93 ± 5 | 60 ± 10* | 46 ± 3* |
The number of independent cell cultures assayed (n) was 3. Statistical analysis was performed using one-way ANOVA with Scheffé comparison test.
P ≤ 0.05 or 0.01 vs. control; the cell viability in all conditions was >90%. The maximal cellular densities were reached for HeLa and MDA-MB-231 cells at day 4; for PC3, 3T3, HFF-1, and DU145 cells at day 5; for Colo-205, MCF-7, A549, and SiHa cells at day 6; and for HCT 116 cells at day 7.